Moderator: NMI, NSADD
- May 27, 2020
- in the cockpit
MAPS’ Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Successful Results for Patients with Severe, Chronic PTSD - MAPS
The highly statistically significant results and excellent safety record suggest MDMA-assisted therapy will be an effective treatment for severe, chronic PTSD 67% of participants who received three MDMA-assisted therapy sessions no longer qualified...
Let's give some applause to the amazing people at MAPS! This is a historic moment.